1-octadecanoyl-sn-glycero-3-phosphocholine

1-octadecanoyl-sn-glycero-3-phosphocholine is a lipid of Glycerophospholipids (GP) class. 1-octadecanoyl-sn-glycero-3-phosphocholine is associated with abnormalities such as Septicemia. The involved functions are known as Phosphorylation, MAP kinase activity, Phagocytosis, protein serine/threonine kinase activity and Uptake. The associated genes with 1-octadecanoyl-sn-glycero-3-phosphocholine are FPR1 gene and OLR1 gene. The related lipids are Lysophosphatidylcholines.

Cross Reference

Introduction

To understand associated biological information of 1-octadecanoyl-sn-glycero-3-phosphocholine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 1-octadecanoyl-sn-glycero-3-phosphocholine?

1-octadecanoyl-sn-glycero-3-phosphocholine is suspected in Septicemia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 1-octadecanoyl-sn-glycero-3-phosphocholine

MeSH term MeSH ID Detail
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Arteriosclerosis D001161 86 associated lipids
Hyperlipidemias D006949 73 associated lipids
Total 4

PubChem Associated disorders and diseases

What pathways are associated with 1-octadecanoyl-sn-glycero-3-phosphocholine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 1-octadecanoyl-sn-glycero-3-phosphocholine?

There are no associated biomedical information in the current reference collection.

What functions are associated with 1-octadecanoyl-sn-glycero-3-phosphocholine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 1-octadecanoyl-sn-glycero-3-phosphocholine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 1-octadecanoyl-sn-glycero-3-phosphocholine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 1-octadecanoyl-sn-glycero-3-phosphocholine?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 1-octadecanoyl-sn-glycero-3-phosphocholine

Download all related citations
Per page 10 20 50 | Total 25
Authors Title Published Journal PubMed Link
pmid:
Tang D et al. Quercetin prevents LPS-induced high-mobility group box 1 release and proinflammatory function. 2009 Am. J. Respir. Cell Mol. Biol. pmid:19265175
Vesterqvist O et al. Quantitation of lysophosphatidylcholine molecular species in rat cardiac tissue. 1992 Anal. Biochem. pmid:1514697
Soga T et al. Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor. 2005 Biochem. Biophys. Res. Commun. pmid:15607732
Hui SW and Huang CH X-ray diffraction evidence for fully interdigitated bilayers of 1-stearoyllysophosphatidylcholine. 1986 Biochemistry pmid:3964679
Wu W et al. Lamellar--micellar transition of 1-stearoyllysophosphatidylcholine assemblies in excess water. 1982 Biochemistry pmid:7150539
Mansfield PJ et al. Regulation of polymorphonuclear leukocyte degranulation and oxidant production by ceramide through inhibition of phospholipase D. 2002 Blood pmid:11830497
Berdel WE et al. Early tumor and leukemia response to alkyllysophospholipids in a phase I study. 1982 Cancer pmid:7127246
King MT et al. Failure to detect mutagenic effects of anti-tumor alkyl-lysophospholipids. 1981 Cancer Lett. pmid:6790162
Berdel WE et al. Alkyl-lysophospholipids lack influence on the occurrence of radiation-induced lymphomas and AKR-leukemia. 1983 Cancer Lett. pmid:6686802